SEC Form 4 · accession 0001140361-18-025010
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Blaine Templeman
Officer — Chief Legal Officer
Period of report
May 17, 2018
Accepted (ET)
May 21, 2018 · 6:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 17, 2018 | S | 2,000 | $8.15 | D | 69,937 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2018.
- F2The shares sold were originally acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2018.